Page 275 - Company Results

JB Chemicals & Pharma Q2 PAT up 13% to Rs 111 cr; revenue at Rs 809 cr

The drug firm had logged a profit after tax (PAT) of Rs 98 crore in July-September period of previous fiscal year

Ashok Leyland posts Rs 199 crore net profit in Q2, revenue up 85% YoY

The company has also achieved a market share of 32 per cent in Q2FY23

Adani Power Q2 results: Revenue rises 36%, net profit at Rs 696 crore

Consolidated revenue in Q2 rose 36 per cent year-on-year (YoY) to Rs 7,044 crore due to improved tariff realisation and higher one-time income of Rs 771 crore

ABB India net up 69% to Rs 203 cr in July-Sept quarter on higher revenues

The consolidated net profit of the company stood at Rs 120 crore in the quarter ended September 30, 2021

LIC sees multifold increase in Q2 net profit at Rs 15,952 crore

This is due to transfer of funds from non-par to shareholders' account

Glenmark Pharmaceuticals Q2 PAT rises marginally to Rs 279 crore

The Mumbai-based drug firm had reported a PAT of Rs 275 crore in the July-September period of the previous fiscal

ITI Limited Q2 loss widens to Rs 100 cr, revenue plunges 44% to Rs 197 cr

The company had posted a loss of Rs 55.8 crore in the same period a year ago

LIC Q2 results: PAT rises 11-fold to Rs 15,952 crore; net income up 26%

The net income from investments for Q2 stood at Rs 84,103.64 crore, as compared to Rs 76,533.75 crore in the year-ago period

Ircon International Q2 net up 38% to Rs 174 cr, income rises to Rs 2,305 cr

The consolidated income of the company during the second quarter increased to Rs 2,305.87 crore from Rs 1,582.67 crore in the year-ago period

PhysicsWallah's revenue rises to Rs 232.48 cr, net profit surges 14 times

The company has reported a profit at a time when top tech unicorns, especially edtech firms are incurring steep losses and are laying-off employees

Suryoday SFB reports Rs 13-cr Q2 net against Rs 1.92-cr loss a year ago

On a sequential basis, the bank's net profit rose 67.7 per cent from Rs 7.75 crore in April-June

GlaxoSmithKline Pharma Q2 net up 3% to Rs 193 cr, revenue down to Rs 906 cr

The drug maker had reported a net profit from continuing operations at Rs 187 crore in the July-September period of the previous fiscal

Fortis Healthcare sees strong growth in hospital revenues in Q2FY23

Q2FY23 hospital business revenues stood at Rs 1,297 crore versus Rs 1,098.5 crore in Q2FY22 and Rs 1,192.4 crore in Q1FY23

Alembic Pharma Q2 net profit dips 19% to Rs 133 crore on higher expenses

Expenses during the period under review stood at Rs 509 crore as compared to Rs 428 crore earlier

GMR Power & Urban Infra Q2 net profit rises over four-fold to Rs 1,083 cr

However, on a standalone basis, the company reported a loss of Rs 46.40 crore in the latest September quarter

Pfizer India Q2 PAT rises to Rs 226 crore on lower costs, price hikes

Its cost of materials consumed fell 2.1% to Rs 94.4 crore, accounting for about 21% of total expenses in the quarter

NLC India reports 111.6% rise in Q2 profit to Rs 417 cr on higher revenues

The company had posted a consolidated profit of Rs 197.02 crore in the year-ago period, NLC India said in a filing to BSE

SJVN Q2 net profit rises 10% to Rs 445 cr, income dips to Rs 916 cr

Its total income dipped to Rs 916.25 crore in the quarter from Rs 925.56 crore a year ago

Thermax Q2 net up 24% to Rs 109 cr, revenue surges 41% to Rs 2,075 cr

Order booking in the quarter grew 9 per cent to Rs 2,015 crore compared to Rs 1,856 crore

BHEL posts Rs 12.10 cr Q2 net on higher revenues, income up to Rs 5,418 cr

Its total income rose to Rs 5,418.74 crore in the quarter from Rs 5,197.25 crore a year ago